SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-049765
Filing Date
2021-02-22
Accepted
2021-02-22 06:08:59
Documents
15
Period of Report
2021-02-22

Document Format Files

Seq Description Document Type Size
1 6-K d140178d6k.htm 6-K 8511
2 EX-99.1 d140178dex991.htm EX-99.1 452575
3 GRAPHIC g140178dsp21.jpg GRAPHIC 1788
4 GRAPHIC g140178dsp22a.jpg GRAPHIC 2114
5 GRAPHIC g140178dsp23a.jpg GRAPHIC 1458
6 GRAPHIC g140178dsp23b.jpg GRAPHIC 1827
7 GRAPHIC g140178dsp23c.jpg GRAPHIC 1199
8 GRAPHIC g140178dsp_024.jpg GRAPHIC 12598
9 GRAPHIC g140178g0219165713875.jpg GRAPHIC 1580
10 GRAPHIC g140178page001a.jpg GRAPHIC 17008
11 GRAPHIC g140178page001b.jpg GRAPHIC 5146
12 GRAPHIC g140178page002.jpg GRAPHIC 11197
13 GRAPHIC g140178page004.jpg GRAPHIC 415458
14 GRAPHIC g140178page005.jpg GRAPHIC 202764
15 GRAPHIC g140178snap3.jpg GRAPHIC 51476
  Complete submission text file 0001193125-21-049765.txt   1455195
Mailing Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141
Business Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141 61 3 9826 0399
Opthea Ltd (Filer) CIK: 0001815620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-39621 | Film No.: 21658158
SIC: 2836 Biological Products, (No Diagnostic Substances)